These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4397178)

  • 1. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):407-11. PubMed ID: 4397178
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the action of m-tyrosine on blood pressure in the conscious rat: evidence for a central hypotensive effect.
    Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):412-9. PubMed ID: 4397179
    [No Abstract]   [Full Text] [Related]  

  • 3. Further studies on the mechanism of the central hypotensive effect of L-dopa, DL-m-tyrosine and L-alpha-methyldopa.
    Rubenson A
    J Pharm Pharmacol; 1971 Mar; 23(3):228-30. PubMed ID: 4396899
    [No Abstract]   [Full Text] [Related]  

  • 4. 4,4,6-trimethyl-3,4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-beta-hydroxylation in vivo.
    Porter CC; Torchiana ML
    Biochem Pharmacol; 1971 Jan; 20(1):183-91. PubMed ID: 4398314
    [No Abstract]   [Full Text] [Related]  

  • 5. Antagonistic actions of alpha-methylnoradrenaline derived from alpha-methyldopa.
    Boakes RJ; Candy JM; Wolstencroft JH
    J Pharm Pharmacol; 1973 Jun; 25(6):491-2. PubMed ID: 4146591
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood pressure and noradrenaline levels after treatment with alpha-methyldopa, alpha-methyldopamine and alpha-methyl-m-tyrosine.
    Henning M
    J Pharm Pharmacol; 1967 Nov; 19(11):775-9. PubMed ID: 4383705
    [No Abstract]   [Full Text] [Related]  

  • 7. On the localization of the hypotensive effect of L-dopa.
    Henning M; Rubenson A; Trolin G
    J Pharm Pharmacol; 1972 Jun; 24(6):447-51. PubMed ID: 4403826
    [No Abstract]   [Full Text] [Related]  

  • 8. Further evidence for a central hypotensive action of -methyldopa.
    Finch L; Haeusler G
    Br J Pharmacol; 1972 May; 45(1):167P-168P. PubMed ID: 5041484
    [No Abstract]   [Full Text] [Related]  

  • 9. The significance of the relative potencies of norepinephrine and alpha-methylnoradrenaline for the mode of action of alpha-methyldopa.
    Trinker FR
    J Pharm Pharmacol; 1971 Apr; 23(4):306-8. PubMed ID: 4396912
    [No Abstract]   [Full Text] [Related]  

  • 10. An investigation of alpha-methyl amino-acids and their derivatives on isolated tissue preparations.
    Gulati OD; Parikh HM; Ringe SY; Sherlekar ML
    Br J Pharmacol; 1970 Dec; 40(4):689-701. PubMed ID: 5495174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. -Sympathetic receptor stimulation in the brain and hypotensive activity of -methyldopa.
    Heise A; Kroneberg G
    Eur J Pharmacol; 1972 Feb; 17(2):315-7. PubMed ID: 4402101
    [No Abstract]   [Full Text] [Related]  

  • 12. On the role of alpha-methyldopamine in the antihypertensive effect of alpha-methyldopa.
    Waldmeier P; Hedwal PR; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(3):303-14. PubMed ID: 169487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat.
    Finch L; Haeusler G
    Br J Pharmacol; 1973 Feb; 47(2):217-28. PubMed ID: 4722038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central hypotensive effect of alpha-methyldopa.
    Henning M; van Zwieten PA
    J Pharm Pharmacol; 1968 Jun; 20(6):409-17. PubMed ID: 4386523
    [No Abstract]   [Full Text] [Related]  

  • 15. Liberation of alpha-methyldopamine as a "false" sympathetic transmitter after pretreatment of cats with alpha-methyldopa and disulfiram.
    Thoenen H; Haefely W; Gey KF; Hürlmann A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(2):181-96. PubMed ID: 4385111
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the mode of action of alpha-methyldopa.
    Henning M
    Acta Physiol Scand Suppl; 1969; 322():1-37. PubMed ID: 4311985
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the formation of alpha-methylnoradrenaline in hypertensive patients treated with alpha-methyldopa.
    Muscholl E; Rahn KH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(2):215-6. PubMed ID: 4232699
    [No Abstract]   [Full Text] [Related]  

  • 18. L-DOPA induced effects on motor activity in mice after inhibition of dopamine-beta-hydroxylase.
    Strömberg U; Svensson TH
    Psychopharmacologia; 1971; 19(1):53-60. PubMed ID: 5089105
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of central serotonin neurons in the hypotensive action of methyldopa in the rat.
    Choy VJ; Chalmers J
    Clin Exp Pharmacol Physiol; 1984; 11(1):37-44. PubMed ID: 6713735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular activity of alpha methyldopa metabolites in the dog].
    Wepierre J; Doreau C; Papin A; Paultre C; Cohen Y
    Arch Int Pharmacodyn Ther; 1973 Nov; 206(1):135-49. PubMed ID: 4149582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.